Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $31.5 million.

  • Metagenomi's Operating Expenses fell 707.73% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.2 million, marking a year-over-year decrease of 1419.12%. This contributed to the annual value of $141.2 million for FY2024, which is 1456.25% up from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Operating Expenses is $31.5 million, which was down 707.73% from $29.5 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Operating Expenses registered a high of $40.2 million during Q1 2024, and its lowest value of $26.6 million during Q1 2023.
  • Moreover, its 3-year median value for Operating Expenses was $31.9 million (2025), whereas its average is $32.5 million.
  • As far as peak fluctuations go, Metagenomi's Operating Expenses soared by 5112.24% in 2024, and later plummeted by 2051.21% in 2025.
  • Over the past 3 years, Metagenomi's Operating Expenses (Quarter) stood at $32.6 million in 2023, then fell by 7.23% to $30.2 million in 2024, then grew by 4.17% to $31.5 million in 2025.
  • Its Operating Expenses stands at $31.5 million for Q3 2025, versus $29.5 million for Q2 2025 and $31.9 million for Q1 2025.